<p>Optic neuropathies are conditions in which there is damage to the optic nerve (ON) caused by a variety of causes including glaucoma inflammation gene abnormalities ischemia trauma and toxicity. ON damage triggers a process of axon degeneration inflammatory cytokine upregulation breakdown of the blood-optic nerve barrier and eventually the induction of apoptosis of retinal ganglion cells (RGCs) resulting in optic atrophy. To date there is no effective treatment for most optic neuropathies; however because the damage initially is axogenic there may exist a window of therapeutic opportunity before the death of RGCs. Thus the search for effective treatments for various optic neuropathies before there is permanent damage to prevent or limit visual dysfunction and the development of methods to stimulate axon and/or RGC regeneration to restore vision after damage has occurred is pivotal.</p><p><br></p><p>This reprint collected 19 articles published in this Special Issue of&nbsp;<em>IJMS&nbsp;</em>which&nbsp;covers the molecular mechanisms to protect RGCs and/or axonal damage translational research gene therapy regenerative medicine and neuroprotection for glaucoma.</p><p><br></p><p><br></p>
Piracy-free
Assured Quality
Secure Transactions
Delivery Options
Please enter pincode to check delivery time.
*COD & Shipping Charges may apply on certain items.